J 2003

Prolactin levels in risperidone treatment of first episode schizophrenia.

ČEŠKOVÁ, Eva; Radovan PŘIKRYL; Tomáš KAŠPÁREK a Marta ONDRUŠOVÁ

Základní údaje

Originální název

Prolactin levels in risperidone treatment of first episode schizophrenia.

Název anglicky

Prolactin levels in risperidone treatment of first episode schizophrenia.

Autoři

ČEŠKOVÁ, Eva; Radovan PŘIKRYL; Tomáš KAŠPÁREK a Marta ONDRUŠOVÁ

Vydání

International Journal of Psychiatry in Clinical Practice, 2003, 1365-1501

Další údaje

Jazyk

čeština

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 0.191

Kód RIV

RIV/00216224:14110/03:00021237

Organizační jednotka

Lékařská fakulta

UT WoS

000220242100006

Klíčová slova anglicky

prolactin; risperidone; schizophrenia

Štítky

Změněno: 23. 6. 2009 11:23, prof. MUDr. Eva Češková, CSc.

Anotace

ORIG EN

V originále

Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.

Anglicky

Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.